Prelude Therapeutics (PRLD)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.04
0.02 (1.96%)
At close: Jan 15, 2025, 2:33 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -2.12 | -2.67 | -5.35 | -54.93 | -30.79 | -57.3 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.09 | 1.46 | 2.07 | 14.74 | -17.18 | -37.07 |
P/FCF Ratio | -2.33 | -3.3 | -6.9 | -66.82 | -32.1 | -62.39 |
P/OCF Ratio | -2.41 | -3.42 | -7.09 | -67.72 | -33.08 | -64.94 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.07 | 0.01 | 0.01 | n/a | -0.01 | n/a |
Quick Ratio | 10.79 | 9.42 | 15.37 | 19.41 | 4.18 | 6.37 |
Current Ratio | 10.79 | 9.42 | 15.37 | 19.41 | 4.18 | 6.37 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.51 | -0.55 | -0.39 | -0.27 | 0.56 | 0.65 |
Return on Assets (ROA) | -0.44 | -0.49 | -0.36 | -0.25 | -1.26 | -0.89 |
Return on Capital (ROIC) | -0.52 | -0.62 | -0.4 | -0.28 | -1.65 | -1.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |